Guizhou Sanli Pharmaceutical Competitors and Similar CompaniesClear all

Guizhou Sanli Pharmaceutical's competitors and similar companies include Ozon Pharm, Laurus Labs, Grunenthal and EFFIK International.

	Guizhou Sanli Pharmaceutical Guizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products.	Ozon Pharm Ozon Pharm is a pharmaceutical company that manufactures medicines.	Laurus Labs Laurus Labs is a pharmaceutical company.	Grunenthal Grunenthal is a pharmaceutical company.	EFFIK International EFFIK International is a pharmaceutical laboratory.
Founding Date	Founding Date 1995	Founding Date 2003	Founding Date 2005	Founding Date 1946	Founding Date 1992
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma	Tags Healthcare clinical research drug development pharma
Locations	Locations An Shun Shi, CN HQ	Locations Zhigulevsk, RU HQ	Locations Hyderabad, IN HQ Hamburg, DE Turkapally, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN see more	Locations Aachen, DE HQ Brunn Am Gebirge, AT Zaventem, BE Santiago, CL Apartadó, CO København, DK see more	Locations Anderlecht, BE HQ Meudon, FR
Employees	Employees 2,85225% increase	Employees 4691% increase	Employees 5,75359% increase	Employees 4,590	Employees 219
Financial
Revenue (est.)	Revenue (est.) ¥2.1b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) ₹68.1b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ¥650m (FY, 2024)	Cost of goods N/A	Cost of goods ₹27b (FY, 2026)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ¥1.5b (FY, 2024)	Gross profit N/A	Gross profit ₹41.7b (FY, 2026)	Gross profit N/A	Gross profit N/A
Net income	Net income ¥279.8m (FY, 2024)	Net income N/A	Net income ₹8.9b (FY, 2026)	Net income N/A	Net income N/A